ConductScience.org, home

Paper39211396

Treatment Pathways in Patients With Crohn's Disease and Ulcerative Colitis: Understanding the Road to Advanced Therapy.

Siegel CA and 5 others. Crohns Colitis 360, 2024. Cited by 13 papers, by iCite.

Cite this record

ConductScience Library. Treatment Pathways in Patients With Crohn's Disease and Ulcerative Colitis: Understanding the Road to Advanced Therapy. Papers, record 39211396. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39211396

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Treatment Pathways in Patients With Crohn's Disease and Ulcerative Colitis: Understanding the Road to Advanced Therapy.
PubMed
Journal
Crohns Colitis 360
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
13
iCite
Relative citation ratio, by iCite
2.31, provisional
iCite
Revised in PubMed
2024-09-02
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Siegel CACorey Ahttps://orcid.org/0000-0002-2240-6605
2Sharma DDolly
3Griffith JJenny
4Doan QQuynhchau
5Xuan SSi
6Malter LLisa

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References21

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
134513436A Review of Four Practice Guidelines of Inflammatory Bowel Disease.Cureus2021https://conductscience.org/library/papers/34513436PubMed
229562277Quality of Life in Inflammatory Bowel Disease: A Systematic Review and Meta-analyses-Part I.Inflamm Bowel Dis2018https://conductscience.org/library/papers/29562277PubMed
335956201Machine Learning Can Predict the Probability of Biologic Therapy in Patients with Inflammatory Bowel Disease.J Clin Med2022https://conductscience.org/library/papers/35956201PubMed
433159475Fatigue in inflammatory bowel disease and its impact on daily activities.Aliment Pharmacol Ther2021https://conductscience.org/library/papers/33159475PubMed
537506265Early Biologic Treatment Decreases Risk of Surgery in Crohn's Disease but not in Ulcerative Colitis: Systematic Review and Meta-Analysis.Inflamm Bowel Dis2024https://conductscience.org/library/papers/37506265PubMed
633885977Evidence-based clinical practice guidelines for inflammatory bowel disease 2020.J Gastroenterol2021https://conductscience.org/library/papers/33885977PubMed
732100018Identifying IBD Providers' Knowledge Gaps Using a Prospective Web-based Survey.Inflamm Bowel Dis2020https://conductscience.org/library/papers/32100018PubMed
833663650Health Care Utilization Among U.S. Adults With Inflammatory Bowel Disease, 2015-2016.Natl Health Stat Report2021https://conductscience.org/library/papers/33663650PubMed
933569628Long-term cost and complications of surgery in patients with ulcerative colitis: a claims data analysis.Int J Colorectal Dis2021https://conductscience.org/library/papers/33569628PubMed
1032026526Knowledge of disease and self-management of adolescents with inflammatory bowel diseases.Acta Paediatr2020https://conductscience.org/library/papers/32026526PubMed
1131945371AGA Clinical Practice Guidelines on the Management of Moderate to Severe Ulcerative Colitis.Gastroenterology2020https://conductscience.org/library/papers/31945371PubMed
1238402895
A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn's disease (PROFILE): a multicentre, open-label randomised controlled trial.
Lancet Gastroenterol Hepatol2024https://conductscience.org/library/papers/38402895PubMed
1325989464Assessing fatigue in inflammatory bowel disease: comparison of three fatigue scales.Aliment Pharmacol Ther2015https://conductscience.org/library/papers/25989464PubMed
1427269903Report: economic implications of inflammatory bowel disease and its management.Am J Manag Care2016https://conductscience.org/library/papers/27269903PubMed
1533079065Developing Patient-Centered Inflammatory Bowel Disease-Related Educational Videos Optimized for Social Media: Qualitative Research Study.JMIR Med Educ2020https://conductscience.org/library/papers/33079065PubMed
1634051983AGA Clinical Practice Guidelines on the Medical Management of Moderate to Severe Luminal and Perianal Fistulizing Crohn's Disease.Gastroenterology2021https://conductscience.org/library/papers/34051983PubMed
1736777424Indicators of Suboptimal Treatment and Associated Healthcare Costs Among Patients With Crohn's Disease Initiated on Biologic or Conventional Agents.Crohns Colitis 3602022https://conductscience.org/library/papers/36777424PubMed
1829688466Quality of Life in Inflammatory Bowel Disease: A Systematic Review and Meta-analyses-Part II.Inflamm Bowel Dis2018https://conductscience.org/library/papers/29688466PubMed
1918295023Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial.Lancet2008https://conductscience.org/library/papers/18295023PubMed
2033359090
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD.
Gastroenterology2021https://conductscience.org/library/papers/33359090PubMed

See all 21 referencesDownload CSV of references

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.

PMIDTitleJournalYearIn PapersSource
42943287Changing Prescription Patterns in Pharmacologically Treated Patients with Newly Diagnosed Inflammatory Bowel Disease in German Gastroenterology Practices: A Real-World Study, 2015-2024.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/42943287PubMed
42523912The efficacy and safety of etrasimod as a first-line advanced therapy for ulcerative colitis: prespecified and post hoc subgroup data from the ELEVATE UC clinical program.Ther Adv Gastroenterol2026https://conductscience.org/library/papers/42523912PubMed
42231661
Understanding Patient and Gastroenterologist Preferences at the Time of Treatment Escalation to First-Line Advanced Therapy in Ulcerative Colitis: A Discrete Choice Experiment in Five European Countries.
United European Gastroenterol J2026https://conductscience.org/library/papers/42231661PubMed
41884650Redefining Early Intervention and the Window of Opportunity in Crohn's Disease.Gastroenterol Hepatol (N Y)2026https://conductscience.org/library/papers/41884650PubMed
41125135
Anti-tumor necrosis factor treatment from diagnosis is more effective and less costly than conventional "step-up" care for patients with active Crohn's disease: a cost-effectiveness analysis from the PROFILE trial.
J Crohns Colitis2025https://conductscience.org/library/papers/41125135PubMed
40848228Cost-Utility Analysis of Treatment Sequences for Moderate-to-Severe Crohn's Disease.Pharmacoeconomics2025https://conductscience.org/library/papers/40848228PubMed
4059122820-Year Mortality in a Population-Based Cohort of Patients with Inflammatory Bowel Disease from New Zealand.Dig Dis Sci2025https://conductscience.org/library/papers/40591228PubMed
40339064Disparities in Access and Treatment for Rural Patients With Inflammatory Bowel Disease: A Survey of Inflammatory Bowel Disease Patients and Providers.Inflamm Bowel Dis2025https://conductscience.org/library/papers/40339064PubMed
40222016Safety Outcomes in Patients With Ulcerative Colitis Using a Healthcare Administrative Database in the United States.Inflamm Bowel Dis2025https://conductscience.org/library/papers/40222016PubMed
39740876Microbiome and Mucosal Immunity in the Intestinal Tract.In Vivo2025https://conductscience.org/library/papers/39740876PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39211396

GET https://conductscience.org/api/papers/v1/39211396/references?page=2